Chemicals

tris(2-ethylhexyl) benzene-1,2,4-tricarboxylate

We are tris(2-ethylhexyl) benzene-1,2,4-tricarboxylate CAS:3319-31-1 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Synonyms：

Kodaflex TOTM

triethylhexyl trimellitate

Tris(2-ethylhexyl) Trimellitate

Hatcol 200

Trioctyl benzene-1,2,4-tricarboxylate

Trioctyl Trimellitate

Trimellitic Acid Tris(2-ethylhexyl) Ester

Monosizer W710L

Morflex 510

2-ethylhexyl trimellitate

Staflex TOTM

Tris(2-ethylhexyl)trimellitate

TOTM (Tris(2-ethylhexyl) trimellitate

Trioctyl 1,2,4-Benzenetricarboxylate

1,2,4-Benzenetricarboxylic Acid Tris(2-ethylhexyl) Ester

Totm

tri-2-ethyl hexyl trimellitate

Molecular Formula: C33H54O6

Molecular Weight: 546.77800

Appearance and properties: colorless or light yellow transparent oily liquid

Density: 0.990 g/mL at 20 °C(lit.)

Boiling point: 414 °C(lit.)

Melting point: 46ºC

Flash point: 505 °F

Refractive index: n20/D 1.485(lit.)

Stability: Stable. Combustible. Incompatible with strong oxidizing agents.

Storage conditions: Keep container closed when not in use. Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances.

Applications: used as a plasticizer for PVC products and heat-resistant cables

Items of Analysis	Standard of Analysis	Test Results
Appearance	Transparent, no visible impurities, oily liquid	Conform
Ester content	≥99.50%	99.85%
Acid value	≤0.10%	0.060%
Moisture	≤0.05%	0.013%
Color	≤50 Pt-Co	20 Pt-Co
Volume resistivity(20℃)	≥6.0×10¹¹	16.58×10¹¹
Flash point	≥245℃	256℃
Density (20℃)	0.984-0.991 g/cm³	0.989 g/cm³
Heating loss(125℃×3hrs)	≤0.1%	0.04%
DOP/DEPH	≤500 ppm	N/A
2-Ethyl hexanol	≤1000 ppm	N/A
Antioxidant content	≤3000 ppm	1500
Index of Refraction(nD20℃)	1.482-1.488	1.485
Conclusion	Conforms to Factory Standard

tris(2-ethylhexyl) benzene-1,2,4-tricarboxylate

Related News: “CAR T-cell therapy continues to deliver remarkable outcomes for patients with hematologic malignancies, and next-generation approaches are needed to enable broad and timely patient access and reduce the cost and complexity of therapy,” said Scott Wolchko, President and Chief Executive Officer of Fate Therapeutics.1-(4-methylbenzyl)piperazine dihydrochloride “CAR T-cell therapy continues to deliver remarkable outcomes for patients with hematologic malignancies, and next-generation approaches are needed to enable broad and timely patient access and reduce the cost and complexity of therapy,” said Scott Wolchko, President and Chief Executive Officer of Fate Therapeutics.α-D-Glcp-(1-)2)-D-Glcp The latest outbreak comes as China grapples with an African swine fever epidemic that has infected tens of thousands of pigs. It could stoke more worries among its people about the country’s food supply.Silane, trimethyl(tricosyloxy)- According to the “2013-2018 New Drug Review Summary” report, from 2013 to 2018, new drug applications have shown a year-on-year growth trend. In 2018, domestically produced Class 1 new drugs have declared 225 varieties, the highest in 10 years.The Philippines reported its first Wuhan coronavirus fatality on Sunday.

Product Name
2-[[(2S)-4-methyl-2-[(2-methylpropan-2-yl)oxycarbonylamino]pentanoyl]amino]acetic acid	View Details
Methyl 3-methylthiopropionate Cas:13532-18-8	View Details
S-(4,4,5,5,5-Pentafluoropentyl)isothiourea Methanesulfonate	View Details